Aeterna Zentaris Inc (AEZS.OQ)
AEZS.OQ on NASDAQ Stock Exchange Capital Market
1.91USD
20 Jul 2018
1.91USD
20 Jul 2018
Change (% chg)
$-0.02 (-1.04%)
$-0.02 (-1.04%)
Prev Close
$1.93
$1.93
Open
$1.94
$1.94
Day's High
$1.94
$1.94
Day's Low
$1.88
$1.88
Volume
8,444
8,444
Avg. Vol
22,735
22,735
52-wk High
$3.29
$3.29
52-wk Low
$1.12
$1.12
About
Aeterna Zentaris Inc is a specialty biopharmaceutical company engaged in developing and commercializing treatments in oncology, endocrinology and women's health. The Company operates through the biopharmaceutical segment. The Company is engaged in drug development activities and in the promotion of products for others. The... (more)
Overall
| Beta: | 0.84 |
| Market Cap(Mil.): | $34.19 |
| Shares Outstanding(Mil.): | 16.21 |
| Dividend: | -- |
| Yield (%): | -- |
Financials
BRIEF-Aeterna Zentaris Reports Qtrly Earnings Per Share $0.87
* AETERNA ZENTARIS REPORTS FIRST QUARTER 2018 FINANCIAL AND OPERATING RESULTS
BRIEF-Aeterna Zentaris Qtrly Loss Per Share $0.03
* AETERNA ZENTARIS REPORTS FOURTH QUARTER AND FULL-YEAR 2017 FINANCIAL AND OPERATING RESULTS
BRIEF-Aeterna Zentaris Appoints James Clavijo As CFO
* AETERNA ZENTARIS APPOINTS JAMES CLAVIJO AS CHIEF FINANCIAL OFFICER
BRIEF-Aeterna Zentaris Provides Update On Previously Disclosed Class Action Lawsuit
* AETERNA ZENTARIS PROVIDES UPDATE ON PREVIOUSLY DISCLOSED CLASS ACTION LAWSUIT
Competitors
| Price | Chg | |
|---|---|---|
| Merck & Co., Inc. (MRK.N) | $62.52 | +0.01 |
| Pfizer Inc. (PFE.N) | $37.33 | -0.03 |
| Astellas Pharma Inc (4503.T) | ¥1,808 | +0.50 |
| Sanofi SA (SASY.PA) | €72.36 | +0.25 |
| Abbott Laboratories (ABT.N) | $63.32 | -0.46 |
| GlaxoSmithKline Pharmaceuticals Limited (GLAX.NS) | Rs2,769.15 | -1.50 |
| Actavis Inc (WATS.O) | -- | -- |
| Recordati SpA (RECI.MI) | €31.20 | +1.17 |
| Kissei Pharmaceutical Co Ltd (4547.T) | ¥3,110 | -15.00 |
| Novartis AG (NOVN.S) | CHF82.20 | +1.24 |
Estimates